A. S. Sarhan and A. S. Naji, “Clinical Outcomes and Safety of Pembrolizumab Monotherapy in Iraqi Patients with Metastatic Lung Cancer and Renal Cell Carcinoma”, MECOJ, vol. 2, no. 2, pp. 59–66, Jun. 2026, doi: 10.61706/MECOJ160228.